CONMED Corp

CNMD

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 52,555Value: $2.1M

# CNMD Signal Note Deerfield's $2.1M initiation in CONMED suggests confidence in the surgical instruments/capital equipment platform, likely ahead of procedure volume recovery post-COVID and potential M&A consolidation in the fragmented OR equipment space. CNMD trades at ~1.2x sales with improving margins; Deerfield's entry signals conviction in operational execution rather than a near-term clinical catalyst, typical of their multi-strategy playbook favoring operational leverage.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: